Botulinum Toxin Versus Active Strength Training in the Treatment of Lateral Epicondylitis (BooST)
Primary Purpose
Epicondylitis, Lateral Humeral, Tennis Elbow
Status
Completed
Phase
Not Applicable
Locations
Finland
Study Type
Interventional
Intervention
Botulinum toxin type A (Botox®, Allergan)
Active strength training and stretching
Sponsored by
About this trial
This is an interventional treatment trial for Epicondylitis, Lateral Humeral focused on measuring Botulinum Toxin Type A, Exercise, Randomized Controlled Trial, Muscle Stretching Exercises, Strength Training, Treatment Outcome
Eligibility Criteria
Inclusion Criteria:
- pain at the lateral side of the elbow over 3 months
- local tenderness on palpation over the lateral epicondyle
- positive Mill's sign
- lateral elbow pain progression on resisted wrist and/or middle finger extension
- involved in working life
Exclusion Criteria:
- bilateral symptoms or simultaneous medial epicondylitis
- verified or suspected cervical radiculopathy or affected limb neuropathy
- congenital or acquired deformities of the elbow
- previous surgery of the elbow
- infection, dislocation, tendon ruptures, or fractures in the area
- systemic musculoskeletal or neurological disorders, incl. rheumatic diseases and fibromyalgia
- allergy, antibodies or other contraindications for botulinum toxin
- severe depression, chronic pain syndrome or somatisation disorder
- ongoing retirement process
- pregnancy or breastfeeding
- current participation in other clinical trials
Sites / Locations
- Department of Physical medicine and Rehabilitation, Seinäjoki Central Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Active strength training and stretching
Botulinum toxin type A injections
Arm Description
Active strength training and stretching
Botulinum toxin type A injections
Outcomes
Primary Outcome Measures
Pain, 100 mm visual analogue scale, change from baseline
Grip strength (pain free and maximal), hydraulic hand dynamometer, change from baseline
Secondary Outcome Measures
Experienced disability, 100 mm visual analogue scale, change from baseline
Isometric wrist extension and flexion strength, digital hanging scale with rigid bench frame, change from baseline
Treatment adverse effects
Economic evaluation of interventions, direct and indirect costs
Days in sick leave
Experienced forearm pain and disability, The Patient-Rated Tennis Elbow Evaluation (PRTEE)
General improvement, 7-point Likert scale
Full Information
NCT ID
NCT00930709
First Posted
June 29, 2009
Last Updated
December 30, 2014
Sponsor
Seinajoki Central Hospital
1. Study Identification
Unique Protocol Identification Number
NCT00930709
Brief Title
Botulinum Toxin Versus Active Strength Training in the Treatment of Lateral Epicondylitis
Acronym
BooST
Official Title
Botulinum Toxin Versus Active Strength Training in Treatment of the Lateral Epicondylitis - A Single-Blinded, Randomized, Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
December 2014
Overall Recruitment Status
Completed
Study Start Date
March 2009 (undefined)
Primary Completion Date
December 2014 (Actual)
Study Completion Date
December 2014 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Seinajoki Central Hospital
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to compare efficacy, feasibility and cost effectiveness of botulinum toxin type A injections to active nine weeks strength training and stretching program in the treatment of the chronic lateral epicondylitis.
The main hypothesis is that the botulinum toxin type A injections may enable more rapid pain relief while strength training may provide better functional results and less relapses during the follow-up.
Detailed Description
INTRODUCTION:
Lateral epicondylitis (tennis elbow) is a frequent repetitive stress injury, affecting the common extensor muscles at the lateral humeral epicondyle. Lateral epicondylitis has a well-known spontaneous healing tendency. Still the prevalence of the chronic lateral epicondylitis is 1.4% in working populations causing significant occupational disability and financial burden.
Systematic reviews of the effectiveness of different treatment modalities for lateral epicondylitis present conflicting results. There are no consistent guidelines for management of the prolonged lateral epicondylitis. Progressive strengthening and stretching exercises as well as botulinum toxin type A injections have been suggested to be effective in treatment of chronic cases. However, there are only a few studies comparing different treatment modalities and botulinum toxin treatment have not been included in any of these.
The purpose of this study is to compare efficacy, feasibility and cost effectiveness of the botulinum toxin type A injections to active nine weeks strength training and stretching program in the treatment of the chronic lateral epicondylitis.
The main hypothesis is that the botulinum toxin type A injections may enable more rapid pain relief while strength training may provide better functional results and less relapses during the follow-up.
SUBJECTS AND METHODS:
A sample size of 120 participants with an equal drop-out rate of 15 % per group was determined in advance to detect a clinically significant 30 percentage points difference in outcome measures between the treatment groups with the minimum success rate of 65 % at the statistical significance level of 0.05 and power of 80 %.
During the recruitment process all patient newly referred to Department of PM&R outpatient clinics in the Seinäjoki Central Hospital due to elbow pain are evaluated by the study investigators. Every eligible patient with written informed consent is recruited. A computerised random number generator is used to draw up an allocation schedule. Patients are allocated in treatment groups via opaque sealed envelopes marked according to the random schedule.
Measurements and training instructions are performed by five trained physical therapists. In addition to detailed personal training instructions given by physical therapist, illustrated instructions as well as instruction video will be provided for patients in the training group. Physical therapists instructing patients do not perform any measurements to enable blinding of assessor. Measurement devices are calibrated regularly according to the manufacturers' recommendations and quality assurance measurements with test weights are performed on regular basis.
The principal statistical analysis will be done on an intention-to-treat basis. Repeated measures of ANCOVA and Cox Proportional Hazard Regression are planned to be used as primary methods. If there will be relapses, more advanced longitudinal models such as Generalised Estimating Equations and Random Coefficient Analysis will be used.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Epicondylitis, Lateral Humeral, Tennis Elbow
Keywords
Botulinum Toxin Type A, Exercise, Randomized Controlled Trial, Muscle Stretching Exercises, Strength Training, Treatment Outcome
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
103 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Active strength training and stretching
Arm Type
Active Comparator
Arm Description
Active strength training and stretching
Arm Title
Botulinum toxin type A injections
Arm Type
Active Comparator
Arm Description
Botulinum toxin type A injections
Intervention Type
Drug
Intervention Name(s)
Botulinum toxin type A (Botox®, Allergan)
Other Intervention Name(s)
Botox®, Allergan, NDC 0023-1145-01
Intervention Description
Two injections of 10-60 units of botulinum toxin type A. Injections are administered with ENMG assisted technique at the baseline and after 13 weeks.
Intervention Type
Behavioral
Intervention Name(s)
Active strength training and stretching
Other Intervention Name(s)
Eccentric strength training
Intervention Description
Training duration 9 weeks, intensified every 3 weeks in supervision of physiotherapist. Training program includes progressive, slow, repetitive wrist and forearm stretching, eccentric muscle strengthening, occupational exercises and upper limb neural mobilization training.
Primary Outcome Measure Information:
Title
Pain, 100 mm visual analogue scale, change from baseline
Time Frame
0, 6, 13, 26, 39, 52 weeks
Title
Grip strength (pain free and maximal), hydraulic hand dynamometer, change from baseline
Time Frame
0, 6, 13, 26, 39, 52 weeks
Secondary Outcome Measure Information:
Title
Experienced disability, 100 mm visual analogue scale, change from baseline
Time Frame
0, 6, 13, 26, 39, 52 weeks
Title
Isometric wrist extension and flexion strength, digital hanging scale with rigid bench frame, change from baseline
Time Frame
0, 6, 13, 26, 39, 52 weeks
Title
Treatment adverse effects
Time Frame
0, 6, 13, 26, 39, 52 weeks
Title
Economic evaluation of interventions, direct and indirect costs
Time Frame
0, 6, 13, 26, 39, 52 weeks
Title
Days in sick leave
Time Frame
0, 6, 13, 26, 39, 52 weeks
Title
Experienced forearm pain and disability, The Patient-Rated Tennis Elbow Evaluation (PRTEE)
Time Frame
0, 6, 13, 26, 39, 52 weeks
Title
General improvement, 7-point Likert scale
Time Frame
0, 6, 13, 26, 39, 52 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
pain at the lateral side of the elbow over 3 months
local tenderness on palpation over the lateral epicondyle
positive Mill's sign
lateral elbow pain progression on resisted wrist and/or middle finger extension
involved in working life
Exclusion Criteria:
bilateral symptoms or simultaneous medial epicondylitis
verified or suspected cervical radiculopathy or affected limb neuropathy
congenital or acquired deformities of the elbow
previous surgery of the elbow
infection, dislocation, tendon ruptures, or fractures in the area
systemic musculoskeletal or neurological disorders, incl. rheumatic diseases and fibromyalgia
allergy, antibodies or other contraindications for botulinum toxin
severe depression, chronic pain syndrome or somatisation disorder
ongoing retirement process
pregnancy or breastfeeding
current participation in other clinical trials
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Aki Vainionpää, M.D., Ph.D.
Organizational Affiliation
Department of Physical Medicine and Rehabilitation, Seinäjoki Central Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Department of Physical medicine and Rehabilitation, Seinäjoki Central Hospital
City
Seinäjoki
ZIP/Postal Code
60220
Country
Finland
12. IPD Sharing Statement
Links:
URL
http://www.epshp.fi/
Description
Seinäjoki Central Hospital homepage
Learn more about this trial
Botulinum Toxin Versus Active Strength Training in the Treatment of Lateral Epicondylitis
We'll reach out to this number within 24 hrs